AU2006284490A1 - Compositions and methods to control angiogenesis with cupredoxins - Google Patents
Compositions and methods to control angiogenesis with cupredoxins Download PDFInfo
- Publication number
- AU2006284490A1 AU2006284490A1 AU2006284490A AU2006284490A AU2006284490A1 AU 2006284490 A1 AU2006284490 A1 AU 2006284490A1 AU 2006284490 A AU2006284490 A AU 2006284490A AU 2006284490 A AU2006284490 A AU 2006284490A AU 2006284490 A1 AU2006284490 A1 AU 2006284490A1
- Authority
- AU
- Australia
- Prior art keywords
- cupredoxin
- peptide
- cells
- residues
- angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70029705P | 2005-07-19 | 2005-07-19 | |
| US60/700,297 | 2005-07-19 | ||
| US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
| US11/244,105 | 2005-10-06 | ||
| US76474906P | 2006-02-03 | 2006-02-03 | |
| US60/764,749 | 2006-02-03 | ||
| US11/436,592 | 2006-05-19 | ||
| US11/436,592 US7381701B2 (en) | 2001-02-15 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| PCT/US2006/027940 WO2007024368A2 (en) | 2005-07-19 | 2006-07-19 | Compositions and methods to control angiogenesis with cupredoxins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2006284490A1 true AU2006284490A1 (en) | 2007-03-01 |
| AU2006284490A8 AU2006284490A8 (en) | 2008-02-28 |
Family
ID=37772089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006284490A Abandoned AU2006284490A1 (en) | 2005-07-19 | 2006-07-19 | Compositions and methods to control angiogenesis with cupredoxins |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1904081A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009502797A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080034905A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006284490A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615555A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2615560A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188691A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008000993A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080829L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007024368A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8158574B2 (en) * | 2004-10-07 | 2012-04-17 | Cdg Therapeutics, Inc. | Compositions and methods to prevent cancer with cupredoxins |
| EP2061498A4 (en) * | 2006-09-14 | 2009-11-04 | Univ Illinois | COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES |
| AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| UA97466C2 (ru) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| AU2006277009A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| JP2008545398A (ja) * | 2005-05-20 | 2008-12-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法 |
| AU2006251742A1 (en) * | 2005-05-20 | 2006-11-30 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating malaria with cupredoxin and cytochrome |
-
2006
- 2006-07-19 WO PCT/US2006/027940 patent/WO2007024368A2/en not_active Ceased
- 2006-07-19 AU AU2006284490A patent/AU2006284490A1/en not_active Abandoned
- 2006-07-19 BR BRPI0615555-3A patent/BRPI0615555A2/pt not_active IP Right Cessation
- 2006-07-19 MX MX2008000993A patent/MX2008000993A/es active IP Right Grant
- 2006-07-19 CA CA002615560A patent/CA2615560A1/en not_active Abandoned
- 2006-07-19 EP EP06787787A patent/EP1904081A4/en not_active Withdrawn
- 2006-07-19 JP JP2008522911A patent/JP2009502797A/ja active Pending
- 2006-07-19 KR KR1020087002477A patent/KR20080034905A/ko not_active Ceased
-
2008
- 2008-01-09 IL IL188691A patent/IL188691A0/en unknown
- 2008-02-15 NO NO20080829A patent/NO20080829L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007024368A3 (en) | 2007-10-11 |
| WO2007024368A2 (en) | 2007-03-01 |
| IL188691A0 (en) | 2008-08-07 |
| AU2006284490A8 (en) | 2008-02-28 |
| KR20080034905A (ko) | 2008-04-22 |
| NO20080829L (no) | 2008-04-02 |
| EP1904081A4 (en) | 2008-12-03 |
| EP1904081A2 (en) | 2008-04-02 |
| CA2615560A1 (en) | 2007-03-01 |
| BRPI0615555A2 (pt) | 2009-07-14 |
| MX2008000993A (es) | 2008-03-19 |
| JP2009502797A (ja) | 2009-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9107881B2 (en) | Compositions and methods to control angiogenesis with cupredoxins | |
| US8623816B2 (en) | Compositions and methods for treating malaria with cupredoxin and cytochrome | |
| US8232244B2 (en) | Compositions and methods to prevent cancer with cupredoxins | |
| US10889621B2 (en) | Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins | |
| CA2582164A1 (en) | Cupredoxin derived transport agents and methods of use thereof | |
| EP1653990A1 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
| SG174784A1 (en) | Compositions and methods to prevent cancer with cupredoxins | |
| CA2608512A1 (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins | |
| US20080221015A1 (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof | |
| CA2615560A1 (en) | Compositions and methods to control angiogenesis with cupredoxins | |
| AU2010201360A1 (en) | Compositions and methods for treating malaria with cupredoxin and cytochrome | |
| CN101272800A (zh) | 使用铜氧还蛋白控制血管发生的组合物和方法 | |
| ZA200602126B (en) | Use of polypeptides of the cupredoxin family in cancer therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH | Corrigenda |
Free format text: IN VOL 22, NO 6, PAGE(S) 671 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE -NAME INDEX UNDER THE NAME THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, APPLICATION NO. 2006284490, UNDER INID (71) CORRECT THE NAME TO READ THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |